Botella A, Delvaux M, Berry P, Frexinos J, Bueno L
Department of Pharmacology, Centre Hospitalier Universitaire de Rangueil, Toulouse, France.
Gastroenterology. 1992 Mar;102(3):779-86. doi: 10.1016/0016-5085(92)90158-u.
The aim of this study was to determine the cholecystokinin (CCK) receptor subtype involved in the direct myogenic effect of CCK on pig ileum. Smooth muscle cells were dispersed from pig ileum circular muscle layer and incubated in the presence of various concentrations of CCK agonists and antagonists. Contraction was assessed by measuring the length of 50 cells and expressed as the percentage decrease in cell length from control. Maximal contraction varied between 19% +/- 3% (gastrin II, 10 nmol/L) and 26% +/- 3% [CCK octapeptide (CCK-8), 10 nmol/L]. EC50 for CCK tetrapeptide (CCK-4) was the same than for pentagastrin (30 pmol/L), which were more potent than CCK-8 (100 pmol/L) and unsulfated gastrin 17 (100 pmol/L), which in turn were more potent than unsulfated CCK heptapeptide (CCK-7; 300 pmol/L) and sulfated gastrin II (300 pmol/L). The maximal contraction induced by synthetic analogs of CCK was 22% +/- 1% for 1 nmol/L JMV 170 and 23% +/- 1% for 10 nmol/L JMV 180. EC50 was 10 pmol/L for JMV 170 and 800 pmol/L for JMV 180. Contraction induced by 10 nmol/L CCK was inhibited as follows: L 365,260 half maximal inhibition (IC50) = 1 nmol/L greater than L 364,718 (IC50 = 90 nmol/L) greater than proglumide (IC50 = 1 mumol/L). Contraction induced by 10 nmol/L unsulfated gastrin 17 was inhibited as follows: L 365,260 (IC50 = 1 pmol/L) greater than L 364,718 (IC50 = 60 nmol/L) greater than proglumide (IC50 = 4 mumol/L). Removal of Ca2+ from the extracellular medium did not alter the contraction induced by CCK-8 (10 nmol/L) but impaired the contraction induced by unsulfated gastrin 17 (10 nmol/L) -56% in Ca(2+)-free medium, -77% in Ca(2+)-free medium plus 2 mmol/L EGTA, and -70% in the presence of 1 mumol/L nifedipine. These results show that the CCK receptor of pig ileum smooth muscle cells is closely similar to the B receptor and is not dependent on an influx of extracellular Ca2+ to induce cell contraction. By contrast, gastrin could act through a specific receptor subtype, the "gastrin receptor," triggering a Ca2+ influx into the cell to induce cell contraction.
本研究的目的是确定参与胆囊收缩素(CCK)对猪回肠直接肌源性作用的CCK受体亚型。从猪回肠环肌层分离出平滑肌细胞,并在不同浓度的CCK激动剂和拮抗剂存在下进行孵育。通过测量50个细胞的长度评估收缩情况,并表示为细胞长度相对于对照的减少百分比。最大收缩率在19%±3%(胃泌素II,10 nmol/L)至26%±3%[CCK八肽(CCK-8),10 nmol/L]之间变化。CCK四肽(CCK-4)的半数有效浓度(EC50)与五肽胃泌素相同(30 pmol/L),它们比CCK-8(100 pmol/L)和未硫酸化的胃泌素17(100 pmol/L)更有效,而CCK-8和未硫酸化的胃泌素17又比未硫酸化的CCK七肽(CCK-7;300 pmol/L)和硫酸化胃泌素II(300 pmol/L)更有效。CCK合成类似物诱导的最大收缩率,1 nmol/L JMV 170为22%±1%,10 nmol/L JMV 180为23%±1%。JMV 170的EC50为10 pmol/L,JMV 180的EC50为800 pmol/L。10 nmol/L CCK诱导的收缩受到如下抑制:L 365,260半数最大抑制浓度(IC50)=1 nmol/L>L 364,718(IC50 = 90 nmol/L)>丙谷胺(IC50 = 1 μmol/L)。10 nmol/L未硫酸化胃泌素17诱导的收缩受到如下抑制:L 365,260(IC50 = 1 pmol/L)>L 364,718(IC50 = 60 nmol/L)>丙谷胺(IC50 = 4 μmol/L)。从细胞外培养基中去除Ca2+不会改变CCK-8(10 nmol/L)诱导的收缩,但会损害未硫酸化胃泌素17(10 nmol/L)诱导的收缩——在无Ca2+培养基中降低56%,在无Ca2+培养基加2 mmol/L乙二醇双乙醚二胺四乙酸(EGTA)中降低77%,在存在1 μmol/L硝苯地平的情况下降低70%。这些结果表明,猪回肠平滑肌细胞的CCK受体与B受体非常相似,且不依赖细胞外Ca2+内流来诱导细胞收缩。相比之下,胃泌素可能通过一种特定的受体亚型“胃泌素受体”发挥作用,触发Ca2+内流进入细胞以诱导细胞收缩。